Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
Balko JM, Cook RS, Vaught DB, Kuba MG, Miller TW, Bhola NE, Sanders ME, Granja-Ingram NM, Smith JJ, Meszoely IM, Salter J, Dowsett M, Stemke-Hale K, González-Angulo AM, Mills GB, Pinto JA, Gómez HL, Arteaga CL.
Balko JM, et al. Among authors: vaught db.
Nat Med. 2012 Jul;18(7):1052-9. doi: 10.1038/nm.2795.
Nat Med. 2012.
PMID: 22683778
Free PMC article.